← Back
$GLUE All transactions

Monte Rosa Therapeutics, Inc.

▼ SELL

$ Value

$9K

Shares

2,062

Price

$4

Filed

Jun 4

Insider

Name

Dunn Edmund

Title

Principal Accounting Officer

CIK

0001989401

Roles

Officer

Transaction Details

Transaction Date

2025-06-03

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

23,732

Footnotes

Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.34 to $4.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Filing Info

Accession No.

0000950170-25-081637

Form Type

4

Issuer CIK

0001826457

Dunn Edmund's History

Date Ticker Type Value
2026-03-02 GLUE M $7K
2026-03-02 GLUE $9K
2026-03-02 GLUE M $0
2026-02-27 GLUE M $337K
2026-02-27 GLUE $456K
2026-02-27 GLUE M $0
2026-01-05 GLUE $16K
2025-06-03 GLUE $9K

Other Insiders at GLUE (90d)

Insider Bought Sold Last
Warmuth Markus
President & CEO
$141K 2026-04-14
Janku Filip
Chief Medical Officer
$179K 2026-02-23
Nickson Philip
Chief Business & Legal Officer
$103K 2026-04-09
Dunn Edmund
Principal Accounting Officer
$465K 2026-03-02
Bowen Matthew
Principal Accounting Officer
2026-04-06